Clinical Trials Browser

Phase 2 × Interventional × Metastatic Castration Resistant Prostate Cancer × Clear all

NCT04869488 2025-01-24

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

Metastatic Castration Resistant Prostate Cancer

NCT03454750 2025-01-08

LU-PSMA

Phase 2 Completed

Metastatic Castration Resistant Prostate Cancer